CD99 and neoplasm: Furthermore, the proliferation marker Ki67 was localised to the CD99-expressing tumour cells (Fig. 6D), and quantification of Ki67+ cells showed a significantly higher tumour burden in the mice implanted with CD99-depleted MDA-MB-231 cells (Fig. 6E).